PCK1 inhibits Warburg effect-related pathways in hepatorenal cell carcinoma by preventing glucose from entering the glycolytic pathway, thereby inhibiting tumor cell growth and promoting tumor cell death [41, 42]. Here, PCK1 is linked to neoplasm.